Results 1 to 10 of about 4,123,279 (296)

Optimization of TMS target engagement: current state and future perspectives [PDF]

open access: yesFrontiers in Neuroscience
Neuromodulation is based on the principle that brain stimulation produces plastic changes in cerebral circuitry. Given the intersubject structural and functional variability, neuromodulation has a personalized effect in the brain.
Pantelis Lioumis   +15 more
doaj   +4 more sources

Development of Cell Permeable NanoBRET Probes for the Measurement of PLK1 Target Engagement in Live Cells

open access: yesMolecules, 2023
PLK1 is a protein kinase that regulates mitosis and is both an important oncology drug target and a potential antitarget of drugs for the DNA damage response pathway or anti-infective host kinases.
Xuan Yang   +7 more
doaj   +3 more sources

Coupling cellular drug-target engagement to downstream pharmacology with CeTEAM [PDF]

open access: yesNature Communications
Cellular target engagement technologies enable quantification of intracellular drug binding; however, simultaneous assessment of drug-associated phenotypes has proven challenging. Here, we present cellular target engagement by accumulation of mutant as a
Nicholas C. K. Valerie   +23 more
doaj   +2 more sources

Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions

open access: yesPharmaceutics, 2021
With more than 90 approved drugs by 2020, therapeutic antibodies have played a central role in shifting the treatment landscape of many diseases, including autoimmune disorders and cancers. While showing many therapeutic advantages such as long half-life
Yu Tang, Yanguang Cao
doaj   +1 more source

Minimal Physiologically-Based Pharmacokinetic (mPBPK) Metamodeling of Target Engagement in Skin Informs Anti-IL17A Drug Development in Psoriasis

open access: yesFrontiers in Pharmacology, 2022
The pharmacologic effect(s) of biotherapeutics directed against soluble targets are driven by the magnitude and duration of free target suppression at the tissue site(s) of action. Interleukin (IL)-17A is an inflammatory cytokine that plays a key role in
Vivaswath S. Ayyar   +7 more
doaj   +1 more source

Nonclinical safety evaluation, pharmacokinetics, and target engagement of Lu AF82422, a monoclonal IgG1 antibody against alpha-synuclein in development for treatment of synucleinopathies

open access: yesmAbs, 2021
Alpha-synuclein is a 15 kDa protein associated with neurodegenerative diseases such as Parkinson disease and multiple-system atrophy where pathological forms of alpha-synuclein aggregate and become neurotoxic.
Lone Fjord-Larsen   +7 more
doaj   +1 more source

Assessing target engagement using proteome-wide solvent shift assays

open access: yeseLife, 2021
Recent advances in mass spectrometry (MS) have enabled quantitative proteomics to become a powerful tool in the field of drug discovery, especially when applied toward proteome-wide target engagement studies.
Jonathan G Van Vranken   +4 more
doaj   +1 more source

Specificity and Durability of Changes in Auditory Processing Efficiency After Targeted Cognitive Training in Individuals With Recent-Onset Psychosis

open access: yesFrontiers in Psychiatry, 2020
BackgroundWe previously demonstrated that the high heterogeneity of response to computerized Auditory Training (AT) in psychosis can be ascribed to individual differences in sensory processing efficiency and neural plasticity.
Bruno Biagianti   +10 more
doaj   +1 more source

Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth

open access: yeseLife, 2022
Drugs that target human thymidylate synthase (hTS), a dimeric enzyme, are widely used in anticancer therapy. However, treatment with classical substrate-site-directed TS inhibitors induces over-expression of this protein and development of drug ...
Luca Costantino   +38 more
doaj   +1 more source

Development of novel ultra-sensitive IL-11 target engagement assays to support mechanistic PK/PD modeling for an anti-IL-11 antibody therapeutic

open access: yesmAbs, 2022
An in-house antibody generation campaign identified a diverse, high affinity set of anti-interleukin-11 (IL-11) monoclonal antibodies (mAbs) to enable successful development of novel, custom ultra-sensitive target engagement assays for detection of “free”
Maria Myzithras   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy